Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul 14:11:1511.
doi: 10.3389/fmicb.2020.01511. eCollection 2020.

Human Cytomegalovirus Primary Infection and Reactivation: Insights From Virion-Carried Molecules

Affiliations
Review

Human Cytomegalovirus Primary Infection and Reactivation: Insights From Virion-Carried Molecules

Yu-Qing Wang et al. Front Microbiol. .

Abstract

Human cytomegalovirus (HCMV), a ubiquitous beta-herpesvirus, is able to establish lifelong latency after initial infection. Periodical reactivation occurs after immunosuppression, remaining a major cause of death in immunocompromised patients. HCMV has to reach a structural and functional balance with the host at its earliest entry. Virion-carried mediators are considered to play pivotal roles in viral adaptation into a new cellular environment upon entry. Additionally, one clear difference between primary infection and reactivation is the idea that virion-packaged factors are already formed such that those molecules can be used swiftly by the virus. In contrast, virion-carried mediators have to be transcribed and translated; thus, they are not readily available during reactivation. Hence, understanding virion-carried molecules helps to elucidate HCMV reactivation. In this article, the impact of virion-packaged molecules on viral structure, biological behavior, and viral life cycle will be reviewed.

Keywords: HCMV; envelope; primary infection; reactivation; tegument; virion-carried molecules.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Roles of pp71 in the lytic and latent phase. The left panel shows lytic gene expression. Nuclear pp71 is capable of promoting pUL35 to recruit PML, an ND10 component that has impacts on correct localization of Daxx and Sp100. pp71 interacts with Daxx and induces Daxx for degradation in a proteasome-dependent manner. pp71 transactivates IE gene expression, and IE products disrupt ND10. pp71 also has abilities to induce Rb degradation, a process that contributes to relieve Rb-mediated cell cycle block. The right panel shows the latent state and reactivation. pp71 is retained in the cytoplasm or endosome rather than the nucleus. ND10 components represent an intrinsic defense mechanism. Daxx, PML, and bound transcription factors recruit histone deacetylases, resulting in viral gene silencing. LUNA-mediated reactivation is shown in a black circle. LUNA contains isopeptidase activity that deSUMOylates PML and disrupts PML-induced recruitment of Daxx and Sp100. Therefore, LUNA promotes reactivation.

Similar articles

Cited by

References

    1. Adair R., Douglas E. R., Maclean J. B., Graham S. Y., Aitken J. D., Jamieson F. E., et al. (2002). The products of human cytomegalovirus genes UL23, UL24, UL43 and US22 are tegument components. J. Gen. Virol. 83(Pt 6), 1315–1324. 10.1099/0022-1317-83-6-1315 - DOI - PubMed
    1. Adler B., Scrivano L., Ruzcics Z., Rupp B., Sinzger C., Koszinowski U. (2006). Role of human cytomegalovirus UL131A in cell type-specific virus entry and release. J. Gen. Virol. 87(Pt 9), 2451–2460. 10.1099/vir.0.81921-0 - DOI - PubMed
    1. Ahn J. H., Jang W. J., Hayward G. S. (1999). The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10). J. Virol. 73 10458–10471. 10.1128/jvi.73.12.10458-10471.1999 - DOI - PMC - PubMed
    1. Akter P., Cunningham C., McSharry B. P., Dolan A., Addison C., Dargan D. J., et al. (2003). Two novel spliced genes in human cytomegalovirus. J. Gen. Virol. 84(Pt 5), 1117–1122. 10.1099/vir.0.18952-0 - DOI - PubMed
    1. Alcalay M., Tomassoni L., Colombo E., Stoldt S., Grignani F., Fagioli M., et al. (1998). The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol. Cell. Biol. 18 1084–1093. 10.1128/mcb.18.2.1084 - DOI - PMC - PubMed

LinkOut - more resources